Search for articles
Primary peritoneal carcinoma with long term survival. A case report
Alexanderia G. Yatco-Buenaventura, MD, Jan Gayl F. Rodriguez, MD, DPOGS, Maria Roberta D. Merencilla, MD Nephtali M. Gorgonio, MD, FPOGS, Liza Karina I. Gorgonio, MD, FPOGS and Ma. Patricia Luna-Sun, MD, FPOGS, FSGOP
Department of Obstetrics and Gynecology, Cardinal Santos Medical Center
A 51-year-old female with Primary Peritoneal Carcinoma Stage III-C, was initially treated with cytoreductive surgery and intravenous paclitaxel and carboplatin. After 28 months in remission, she developed tumor recurrence. She underwent tumor excision followed by combined intravenous paclitaxel and intraperitoneal carboplatin. The patient is alive and disease-free 5 years after the initial operation.
This case was reported to inform our clinicians that the peritoneum can be the primary site of a rare malignancy. Prognosis may be poor but long-term survival can be achieved in younger patients with good performance status. Having a tumor that is sensitive to platinum-based chemotherapy can contribute to a longer survival even if the tumor was sub-optimally reduced.